| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8669594 | The Journal of Heart and Lung Transplantation | 2018 | 8 Pages |
Abstract
Mid-term survival after Jarvik 2000 implantation was satisfactory and comparable to that reported by other national and international registries (INTERMACS and IMACS) for continuous-flow LVADs. De novo aortic regurgitation occurred despite the intermittent low-speed effect of this device, with some recipients experiencing progressive worsening of aortic regurgitation within 2 years post-implantation.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Hiroki MD, PhD, Goro MD, PhD, Yoshiki MD, PhD, Minoru MD, PhD, Yoshikatsu MD, PhD, Akira MD, PhD, Kenji MD, PhD, Yoshiro MD, PhD, Hiroshi MD, PhD, Hikaru MD, PhD, Soichiro MD, PhD, Takeshi MD, PhD, Shunei MD, PhD,